medigraphic.com

2007, Number 3

<< Back Next >>

Vet Mex 2007; 38 (3)

Clinical performance of dogs with knee degenerative joint disease treated with hyaluronic acid and chondroitin sulfate

Arias SSA, Faria RCM, Gonçalves ME

Language: English/Spanish
References: 50
Page: 331-345
PDF size: 430.00 Kb.


ABSTRACT

El objetivo del presente trabajo fue evaluar la asociación de ácido hialurónico y sulfato de condroitina en el tratamiento de la enfermedad articular degenerativa (EAD) en caninos. En diez perros sin raza defi nida se llevó a cabo la sección del ligamento cruzado craneal, y se confi rmó el desenvolvimiento de la EAD después de 21 días. El ligamento cruzado craneal se sustituyó mediante artrotomía en todos los animales. El tratamiento se inició con ácido hialurónico (AH) y sulfato de condroitina (SC) en cinco perros, el resto se usó como grupo testigo. La deambulación fue evaluada de manera alternada durante 90 días posteriores a la sustitución del ligamento cruzado craneal. Los animales tratados con ácido hialurónico y sulfato de condroitina mostraron menor grado de atrofi a muscular, disminución del grado de claudicación y retorno precoz a la actividad física.


REFERENCES

  1. Harasen G. Canine cranial cruciate ligament rupture in profi le. Can Vet J 2003; 44: 845-846.

  2. Anderson MA, Slater MR, Hammad TA. Results of a survey of small animal practitioners on the perceived clinical effi cacy and safety of an oral nutraceutical. Prev Vet Med 1999; 38: 65-73.

  3. Kuroki K, Cook JL, Kreeger JM. Mechanisms of action and potential uses of hyaluronan in dogs with osteoarthritis. J Am Vet Med Assoc 2002; 221: 944-950.

  4. Hulse D. Treatment methods for pain in the osteoarthritic patient. Vet Clin North Am 1998; 28: 361-375.

  5. Johnson KA, Hulse DA, Hart RC, Kochevart D, Chu Q. Effects of an orally administered mixture of chondroitin sulfate, glucosamine hydrochloride and manganese ascorbate on synovial fl uid chondroitin sulfate 3B3 and 7D4 epitope in a canine cruciate ligament transaction model of osteoarthritis. Osteoarthritis cartilage 2001; 9: 14-21.

  6. Melo EG, Rezende CM, Gomes MG, Freitas PM, Arias SA. Sulfato de condroitina e hialuronato de sódio no tratamento da doença articular degenerativa experimental em cães. Aspectos clínicos e radiológicos. Arq Brás Méd Vet Zootec 2003; 55: 35-43.

  7. McCarthy GM, Donovan JO, Jones B, McAllister H, Seed M et al. Randomized double blind , positive controlled trial to assess the effi cacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis. Vet J 2006: (in press).

  8. Phillips MW. Intra-articular sodium hyaluronate in the horse: a clinical trial. Proc Am Assoc Equine Pract 1980; 26:389-394.

  9. Ruth DT, Swites BJ. Comparision of the effectiveness of intra-articular hyaluronic acid and conventional therapy for the treatment of naturally occurring arthritic conditions in horses. Equine Pract 1985; 7: 25-29.

  10. Abatangelo G, Botti P, Bue M, Gei V, Samson JC, Cortivo R et al. Intraarticular sodium hyaluronate injections in the pond nuki experimental model of osteoarthrithis in dogs. Clin Orthop Relat Res 1989; 241:278-284.

  11. Schiavinato A, Lini E, Guidolin D, Pezzoli G, Botti P, Martelli M et al. Intraarticular sodium hyaluronate injections in the pond nuki experimental model of osteoarthrithis in dogs, Clin Orthop Relat Res 1989; 241:278-284.

  12. Howard RD, McILwraith CW. Sodium hyaluronate in the treatment of equine joint disease. Compend Contin Educ 1993; 15: 473-481.

  13. Keller WG, Aron DN, Rowland GN, Odend´hal S, Brown J. The effect of trans-stiffl e external skeletal fi xation and hyaluronic acid therapy on articular cartilage in the dog. Vet Surg 1994; 23:119-128.

  14. Robles AM, Wainsten L. Mecanismo de acción y uso de precursores de glicosaminoglicanos en la artrosis. Sel Vet 1995; 3:118-121.

  15. Moore MG. Promising responses to a new oral treatment for degenerative joint disorders. Canine Pract 1996; 21:7- 11.

  16. Palmer JL, Bertone AL. Joint biomechanics in the pathogenesis of traumatic arthritis. In: McILwraith CW, Trotter GW, editors. Joint Disease in the Horse, Philadelphia : Saunders, 1996; Chapter 7: 104-119.

  17. McILwraith CW. Use of sodium hyaluronate (Hyaluronan) in equine joint disease. Equine Vet Educ 1997; 9:296-304.

  18. Campos JÁ. Efi cácia do hialuronato de sódio no tratamento sintomático da displasia coxo-femoral em cães. A Hora Vet 1998, 17:59-61.

  19. Gannon JR. Clinical experiences with intravenous use of sodium hyaluronate in racing Greyhounds. Aust Vet J 1998; 76:474-475.

  20. Lipiello L, Idouraine A, McNamara PS, Barr SC, McLaughlin RM. Cartilage stimulatory and antiproteolytic activity is present in sera of dogs treated with a chondroprotective agent. Canine Pract 1999; 24:18-19.

  21. Loneux P, Balligand M. L’ ostéoarthrose chez le chien. Ann Med Vet 1999;143: 153-160.

  22. Souza RL, Raiser AG, Rios MV, Guimarães LD, Araújo L, Leotte AM et al. Precursores de glicosaminoglicanos na reparação articular após trauma iatrogênico no joelho de cães. Clín Vet 1999; 4: 33-38.

  23. White GW, Stites T, Hamm J, Pool R. Evaluation of the effi cacy of various preparations of sodium hyaluronate in an induced equine carpitis model. J Equine Vet Sci 1999; 19: 331.

  24. Homandberg GA, Guo MS, Ray CL, Ding BS. Mixtures of glucosamine and chondroitin sulfate reverse fi bronectin fragment mediated damage to cartilage more effectively than either agent alone. Osteoarthritis Cartilage 2006; 14: 793-806.

  25. Schawalder P. Eigene methoden zur operativen rekonstruktion bei rupturen des voederen und hinteren krenzbandes. Kleintierpraxis1989; 7: 323-330.

  26. Roy RG, Wallace LJ, Johnston GR, Wickstrom SL. A retrospective evaluation of stiffl e osteoarthritis in dogs with bilateral medial patellar luxation and unilateral surgical repair. Vet Surg 1992; 21:475-479.

  27. Doig PA, Purbrick KA, Hare JE, McKeown DB. Clinical efficacy and tolerance of meloxicam in dogs with chronic osteoarthritis. Can Vet J 2000; 41: 296-300.

  28. Hanson RR. Mode of action of oral chondroprotective agents. Canine Pract 1996; 21: 24.

  29. Hanson RR, Smalley LR, Huff GK, White S, Hammad TA. Oral treatment with a glucosamine-chondroitin sulfate compound for degenerative joint disease in horses: 25 cases. Equine Pract 1997; 19:16-21.

  30. Bali JP, Cousse H, Neuzil E. Biochemical of the pharmacologic action of chondroitin sulfates on the osteoarticular system. Sem Arthr Rheum 2001; 31: 58-68.

  31. Dobenecker B, Beetz Y, Kienzle E. A placebocontrolled double blind study on the effect of nutraceuticals (chondroitin sulfate and mussel extract) in dogs with joint diseases as perceived by their owners. J Nutr 2002; 132: 1690s-1691s.

  32. Hoelzler MG, Milis DL, Francis DA, Weigel JP. Results of arthroscopic versus open arthrotomy for surgical management of cranial cruciate ligament defi cience in dogs. Vet Surg 2004; 33: 146-153.

  33. Johnson JM, Johnson AL, Pijanowski GJ, Kneller SK, Schaeffer DJ, Eurell JA et al. Rehabilitation of dogs with surgically treated cranial cruciate ligament-defi cient stifl es by use of electrical stimulation of muscles. Am J Vet Res 1997; 58:1473-1478.

  34. Campbell JR, Duff SRI, Gilbertson EM. The effect on the contralateral stifl e joint of sectioning of the cranial cruciate ligament in the dog. J Small Anim Pract 1982; 23:511-516.

  35. Dahlberg L, Lohmander LS, Ryd R. Intraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain. Arthritis Rheum 1994; 37:521-528.

  36. Frizziero L, Govoni E, Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheum 1998; 16:441-449.

  37. Gaustad G, Larsen S. Comparison of polysulphated glycosaminoglycan and sodium hyaluronate with placebo in treatment of traumatic arthritis in horses. Equine Vet J 1995; 27:356-362.

  38. Dorna V, Guerrero RC. Effects of oral and intramuscular use of chondroitin sulfate in induced equine aseptic arthritis. J Equine Vet Sci 1998; 18:548-555.

  39. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 1993; 20 suppl. 39:3-9.

  40. Auer JA, Fackelman GE, Gingerich DA, Fetter AW. Effect of hyaluronic acid in naturally ocurring and experimental induced osteoarthritis. Am J Vet Res 1980; 41:568-574.

  41. Todhunter RJ, Yeh LA, Sheldon A, Grisanzio L, Walker SL, Burton-Wurster N et al. Effects of strosmelisyn activity on proteoglycan degradation of canine articular explants. Am J Vet Res 1995; 56:1241-1247.

  42. Kasahara M. Effi cacy of intravenous administration of hyaluronic acid for experimentally induced arthritis in horses. Jpn J Vet Res 1997; 45:118.

  43. Listrat V, Ayral X, Patarnello F, Bonvarlet JP, Simonnet J, Amor B et al. Evaluación artroscópica de un potencial efecto modifi cador por el hialuronato de la estructura en artrosis de rodilla. Osteoarthritis Cartilage 1997; 5:153-160.

  44. Huskisson EC, Donelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology 1999; 38: 60-607.

  45. Ronchetti IP, Guerra D, Taparelli F, Boraldi F, Bergamini G, Mori G et al. Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan®) and metilprednisolone acetate (Depomedrol®) in osteoarthritis. Rheumatology 2001; 40: 158-169.

  46. Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis; mechanisms of action. Arthritis Res Ther 2003; 5: 54-67.

  47. Wang y, Prentice LF, Vitetta L, Wluka AE, Circuttini FM. The effect of nutritional supplements on osteoarthritis of the knee. Rheumatology 2004; 9: 275-296.

  48. Vebelhart D, Malaise M, Marcolongo R, DeVathaire F, Piperno M. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate; a one year, randomized, double blind, multicenter study versus placebo. Osteoarthritis Cartilage 2004; 12: 269-276.

  49. Arias SA, Rezende CM, Melo EG, Nunes VA, Correa JC. Avaliação radiological e artroscópica e histologia da membrane sinovial do joelho de cães tratados com associação de sulfato de condroitina e hialuronato de sódio, após doença articular degenerativa induzida experimentalmente. Arq Brás Méd Vet Zootec 2003; 55: 421-429.

  50. Gingerich DA, Auer JA, Fackelman GE. Effect of exogenous hyaluronic acid on joint function in experimentally equine osteoarthritis: dosage titration studies. Res Vet Sci 1981; 30:192-197.




2020     |     www.medigraphic.com